CK Regeon introduces a new Hair Care Program designed to revitalize the scalp environment.
Over 194 million people suffer from androgenic alopecia worldwide, and this number is increasing across all age groups. Current hair care products often fail to meet expectations, so CK Regeon developed a new approach.
Our approach targets Wnt signaling pathways, essential for hair follicle regeneration and regrowth. CXXC5 is overexpressed in miniaturized scalp cells in hair loss patients, contributing to hair loss.
CK Regeon developed PTD-DBM, a peptide that restores Wnt signaling by blocking CXXC5 function, as introduced in the Journal of Investigative Dermatology.
The research led to the creation of KY19382, a key ingredient that mimics the function of PTD-DBM.KY19382 has been shown to stimulate new hair follicle formation, as highlighted in British Journal of Pharmacology.
CK Regeon introduces Heribon, a product implementing the Wnt-ON formula, including KY19382 and Hesperidin, a direct Wnt signaling activator.
Heribon revitalizes hair and scalp health, with its efficacy backed by global patents.
#PTD-DBM, #Hairloss #alopecia, #WNTON, #HERIBON #DERMAREGEON #HAIRREGEON